Monopar Therapeutics (MNPR)
(Delayed Data from NSDQ)
$0.62 USD
+0.02 (3.24%)
Updated May 16, 2024 03:57 PM ET
After-Market: $0.62 0.00 (0.40%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.09 | 0.00% |
Earnings Summary
For their last quarter, Monopar Therapeutics (MNPR) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.17 per share. This reflects a positive earnings surprise of 41.18%. Look out for MNPR's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year increase of 43.75%.
Earnings History
Price & Consensus
Zacks News for MNPR
All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy
MNPR: What are Zacks experts saying now?
Zacks Private Portfolio Services